Clinical Trial Update: Beta-CIT-SPECT and Neurophysiology in Depression [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Beta-CIT-SPECT and neurophysiology in depression has completed, according to sponsor Ludwig-Maximilians-Universität München.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Beta-CIT-SPECT

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Depression | Phase 4 | Status: COMPLETED